Australia markets closed

Citigroup Inc. (C)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
71.18+0.30 (+0.42%)
At close: 4:02PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5144.27B
Enterprise value 3-216.71B
Trailing P/E 7.30
Forward P/E 19.14
PEG ratio (5-yr expected) 10.25
Price/sales (ttm)2.01
Price/book (mrq)0.78
Enterprise value/revenue 3-3.02
Enterprise value/EBITDA 7N/A

Trading information

Stock price history

Beta (5Y monthly) 1.91
52-week change 364.24%
S&P500 52-week change 332.94%
52-week high 380.29
52-week low 340.49
50-day moving average 371.04
200-day moving average 372.05

Share statistics

Avg vol (3-month) 318.68M
Avg vol (10-day) 323.79M
Shares outstanding 52.03B
Implied shares outstanding 6N/A
Float 82.02B
% held by insiders 10.23%
% held by institutions 178.35%
Shares short (30 Aug 2021) 437.44M
Short ratio (30 Aug 2021) 42.35
Short % of float (30 Aug 2021) 41.85%
Short % of shares outstanding (30 Aug 2021) 41.85%
Shares short (prior month 29 July 2021) 432.13M

Dividends & splits

Forward annual dividend rate 42.04
Forward annual dividend yield 42.87%
Trailing annual dividend rate 32.04
Trailing annual dividend yield 32.88%
5-year average dividend yield 42.34
Payout ratio 420.92%
Dividend date 326 Aug 2021
Ex-dividend date 429 July 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 June 2021

Profitability

Profit margin 30.12%
Operating margin (ttm)37.74%

Management effectiveness

Return on assets (ttm)0.95%
Return on equity (ttm)10.97%

Income statement

Revenue (ttm)71.69B
Revenue per share (ttm)34.54
Quarterly revenue growth (yoy)58.30%
Gross profit (ttm)58.37B
EBITDA N/A
Net income avi to common (ttm)20.34B
Diluted EPS (ttm)9.75
Quarterly earnings growth (yoy)486.50%

Balance sheet

Total cash (mrq)961.48B
Total cash per share (mrq)474.39
Total debt (mrq)581.76B
Total debt/equity (mrq)N/A
Current ratio (mrq)N/A
Book value per share (mrq)90.86

Cash flow statement

Operating cash flow (ttm)22.15B
Levered free cash flow (ttm)N/A